DK3400066T3 - Behandlinger og forebyggelse af neonatalt opioidt abstinenssyndrom - Google Patents
Behandlinger og forebyggelse af neonatalt opioidt abstinenssyndrom Download PDFInfo
- Publication number
- DK3400066T3 DK3400066T3 DK17736392.6T DK17736392T DK3400066T3 DK 3400066 T3 DK3400066 T3 DK 3400066T3 DK 17736392 T DK17736392 T DK 17736392T DK 3400066 T3 DK3400066 T3 DK 3400066T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatments
- prevention
- abstinence syndrome
- opioid abstinence
- neonatal
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662276691P | 2016-01-08 | 2016-01-08 | |
| PCT/US2017/012452 WO2017120417A1 (en) | 2016-01-08 | 2017-01-06 | Treatments and prevention of opioid neonatal abstinence syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3400066T3 true DK3400066T3 (da) | 2021-10-18 |
Family
ID=59274434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17736392.6T DK3400066T3 (da) | 2016-01-08 | 2017-01-06 | Behandlinger og forebyggelse af neonatalt opioidt abstinenssyndrom |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10925870B2 (enExample) |
| EP (1) | EP3400066B1 (enExample) |
| JP (1) | JP7061568B2 (enExample) |
| CN (1) | CN108778423A (enExample) |
| AU (1) | AU2017206041B2 (enExample) |
| DK (1) | DK3400066T3 (enExample) |
| WO (1) | WO2017120417A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3066284A1 (en) * | 2018-04-09 | 2019-10-17 | Katana Pharmaceuticals, Inc. | Oxytocin compositions and methods of use |
| EP3883571B1 (en) * | 2019-01-04 | 2026-01-28 | Aether Therapeutics Inc. | 6-beta-naltrexol for use in a method of treating opioid dependency |
| US10653690B1 (en) * | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| US20240325379A1 (en) * | 2021-07-06 | 2024-10-03 | Aether Therapeutics Inc. | Low-dose naltrexol and uses thereof |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4743601A (en) * | 2000-03-15 | 2001-09-24 | Wolfgang Sadee | Neutral antagonists and use thereof in treating drug abuse |
| DE602004009449T2 (de) * | 2003-07-25 | 2008-07-24 | Euro-Celtique S.A. | Behandlung von entzug |
| EP1817023A4 (en) * | 2004-11-16 | 2010-08-18 | Limerick Biopharma Inc | METHODS AND COMPOSITIONS FOR TREATING PAIN |
| CA2702680A1 (en) | 2007-10-18 | 2009-04-23 | Aiko Biotechnology | Combination analgesic employing opioid and neutral antagonist |
| US8748448B2 (en) | 2007-10-18 | 2014-06-10 | Aiko Biotechnology | Combination analgesic employing opioid agonist and neutral antagonist |
| WO2009079489A1 (en) * | 2007-12-17 | 2009-06-25 | The Ohio State University Research Foundation | Methods for screening of opioid receptor neutral antagonists and inverse agonists and uses thereof |
| WO2010065930A1 (en) * | 2008-12-04 | 2010-06-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating or preventing narcotic withdrawal symptoms |
-
2017
- 2017-01-06 EP EP17736392.6A patent/EP3400066B1/en active Active
- 2017-01-06 AU AU2017206041A patent/AU2017206041B2/en active Active
- 2017-01-06 DK DK17736392.6T patent/DK3400066T3/da active
- 2017-01-06 WO PCT/US2017/012452 patent/WO2017120417A1/en not_active Ceased
- 2017-01-06 CN CN201780015234.5A patent/CN108778423A/zh active Pending
- 2017-01-06 JP JP2018535324A patent/JP7061568B2/ja active Active
- 2017-01-06 US US16/068,593 patent/US10925870B2/en active Active
-
2021
- 2021-02-22 US US17/180,945 patent/US12161641B2/en active Active
-
2024
- 2024-12-06 US US18/972,105 patent/US20250177379A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3400066B1 (en) | 2021-07-28 |
| EP3400066A4 (en) | 2019-06-26 |
| US20250177379A1 (en) | 2025-06-05 |
| WO2017120417A1 (en) | 2017-07-13 |
| JP7061568B2 (ja) | 2022-04-28 |
| EP3400066A1 (en) | 2018-11-14 |
| AU2017206041B2 (en) | 2022-07-28 |
| JP2019501194A (ja) | 2019-01-17 |
| US10925870B2 (en) | 2021-02-23 |
| US12161641B2 (en) | 2024-12-10 |
| US20210205296A1 (en) | 2021-07-08 |
| CN108778423A (zh) | 2018-11-09 |
| AU2017206041A1 (en) | 2018-07-26 |
| CA3010609A1 (en) | 2017-07-13 |
| US20190015406A1 (en) | 2019-01-17 |
| NZ744112A (en) | 2025-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3227675T3 (da) | Activin-actrii-antagonister og anvendelser til behandling af myelodysplastisk syndrom | |
| IL263680A (en) | Combination therapies | |
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3129018T3 (da) | Behandling af NAFLD og NASH | |
| DK3429596T3 (da) | Cykliske dinukleotide forbindelser og brugs metoder | |
| PL3523968T3 (pl) | Sposoby kodowania i dekodowania oraz odpowiednie urządzenia | |
| DK3558280T3 (da) | Forebyggelse og behandling af migræne | |
| DK3259597T3 (da) | Pvrig-polypeptider og fremgangsmåder til behandling | |
| PL3402888T3 (pl) | Środki i sposoby leczenia hbv | |
| LT3372229T (lt) | Toninio slopinimo sustiprinimo ir angelmano sindromo gydymo būdai | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| PL3277270T3 (pl) | Kompozycje i sposoby leczenia niedokrwistości | |
| DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
| DK3487505T3 (da) | Indgivelse og dosering af diaminophenothiaziner | |
| DK2964255T3 (da) | Behandling og forebyggelse af fjerntliggende iskæmi-reperfusionsskade (IRI) | |
| DK3242947T3 (da) | Genterapi og elektroporese til behandling af maligniteter | |
| DK3262037T3 (da) | Nyt quinolinderivat til anvendelse til behandling og forebyggelse af virusinfektioner | |
| DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
| EP3426244C0 (en) | 3-phosphoglycerate dehydrogenase inhibitors and uses thereof | |
| DK3261644T3 (da) | Sammensætninger og fremgangsmåder til behandling af nethindenedbrydning | |
| DK3512506T3 (da) | Anvendelse af pridopidin til behandling af retts syndrom | |
| DK3175027T3 (da) | Akustikloftsplader med nedsænkningsbeskyttelsesegenskaber og fremgangsmåder til fremstilling heraf | |
| DK3426243T3 (da) | 3-phosphoglyceratdehydrogenase-inhibitorer og anvendelser deraf | |
| DK3532459T3 (da) | Lsd1-hæmmere og medicinske anvendelser deraf | |
| DK3532059T3 (da) | Kombinationsterapi med bromdomæne- og ekstraterminal proteinhæmmer |